Ignite Creation Date:
2025-12-24 @ 7:52 PM
Ignite Modification Date:
2026-02-07 @ 3:04 PM
Study NCT ID:
NCT04889404
Status:
COMPLETED
Last Update Posted:
2025-04-15
First Post:
2021-05-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS)
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Pancreatic Neoplasms | View |
Keywords: